APA (7th ed.) Citation

VG, V., JP, C., DL, W., WM, C., RS, C., JN, A., . . . VC, J. (2006). Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA: Journal of the American Medical Association, 295(23), 2727. https://doi.org/10.1001/jama.295.23.joc60074

Chicago Style (17th ed.) Citation

VG, Vogel, et al. "Effects of Tamoxifen Vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial." JAMA: Journal of the American Medical Association 295, no. 23 (2006): 2727. https://doi.org/10.1001/jama.295.23.joc60074.

MLA (9th ed.) Citation

VG, Vogel, et al. "Effects of Tamoxifen Vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial." JAMA: Journal of the American Medical Association, vol. 295, no. 23, 2006, p. 2727, https://doi.org/10.1001/jama.295.23.joc60074.